MONDAY, April 29, 2024 -- No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active neovascular age-related macular degeneration (nAMD), according to a study published online April 25 in JAMA Ophthalmology.Ruth E. Hogg, Ph.D., from Queen's University Belfast in the United Kingdom, and colleagues evaluated three vision home-monitoring tests for patients to use to detect active nAMD versus diagnosing active nAMD at hospital follow-up during the after-treatment monitoring phase.

2024年4月29日，星期一——根据4月25日在JAMA眼科在线发表的一项研究，无家庭监测视力测试具有医院眼科服务随访诊所的诊断准确性，可用于识别活动性新生血管性年龄相关性黄斑变性（nAMD）。英国贝尔法斯特女王大学的Ruth E.Hogg博士及其同事评估了三种视觉家庭监测测试，供患者在治疗后监测阶段用于检测活动性nAMD，而不是在医院随访中诊断活动性nAMD。

The analysis included 259 patients (312 eyes; 50 years of age or older) with at least one eye first treated for active nAMD for six months to 42 months before approach.The researchers found that median home-monitoring testing frequency was three times per month (range, one to four). The estimated area under the receiver operating characteristic curve was <0.6 for all home-monitoring tests (the KeepSight Journal, the MyVisionTrack mobile app, and the MultiBit app).

该分析包括259名患者（312只眼；50岁或以上），其中至少一只眼睛在入路前首次接受活动性nAMD治疗6个月至42个月。研究人员发现，家庭监测测试频率的中位数为每月三次（范围为1至4次）。对于所有家庭监测测试（KeepSight Journal，MyVisionTrack移动应用程序和MultiBit应用程序），接收器工作特性曲线下的估计面积均小于0.6。

Only the KeepSight Journal summary score was associated with lesion activity (odds ratio, 3.48).'Results suggest that no home-monitoring vision test evaluated provided satisfactory diagnostic accuracy to identify active nAMD diagnosed in hospital eye service follow-up clinics,' the authors write. 'Implementing any of these evaluated tests, with ophthalmologists only reviewing test positives, would mean most active lesions were missed, risking unnecessary sight loss.'Several authors disclosed financial ties to the pharmaceutical industry.Abstract/Full TextEditorial (subscription or payment may be required)Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox..

只有KeepSight期刊摘要评分与病变活动相关（优势比为3.48）作者写道，结果表明，没有评估的家庭监测视力测试能够提供令人满意的诊断准确性，以识别在医院眼科服务后续诊所诊断出的活动性nAMD实施这些评估测试中的任何一项，眼科医生只审查测试阳性，都意味着错过了大多数活动性病变，有可能导致不必要的视力丧失。”几位作者透露了与制药行业的财务关系。摘要/全文编辑（可能需要订阅或付款）无论您感兴趣的主题是什么，都可以订阅我们的新闻稿，在您的收件箱中获得Drugs.com的最佳信息。。